|
Renal Denervation Therapy Seen As Future Medtech Growth Driver
Renal denervation may be the cardio growth story of the next several years, analysts who attended last month’s Transcatheter Cardiovascular Therapeutics (TCT) Conference in Miami predict.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives